Grzegorz W Basak

Grzegorz W Basak

UNVERIFIED PROFILE

Are you Grzegorz W Basak?   Register this Author

Register author
Grzegorz W Basak

Grzegorz W Basak

Publications by authors named "Grzegorz W Basak"

Are you Grzegorz W Basak?   Register this Author

56Publications

1520Reads

19Profile Views

Kidney dysfunction after hematopoietic cell transplantation-Etiology, management, and perspectives.

Hematol Oncol Stem Cell Ther 2018 Dec 29;11(4):195-205. Epub 2018 Jul 29.

Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2018.07.004DOI Listing
December 2018

Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease.

Eur J Gastroenterol Hepatol 2017 May;29(5):495-502

Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000833DOI Listing
May 2017

Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.

J Clin Virol 2016 Mar 12;76:30-5. Epub 2016 Jan 12.

Department of Haematopoietic Stem Cell Transplantation, Institute of Haematology and Transfusion Medicine, 14 Gandhi Str., 02-776 Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2016.01.005DOI Listing
March 2016

Incidence of adenoviral DNAemia in Polish adults undergoing allogeneic haematopoietic stem cell transplantation.

Arch Immunol Ther Exp (Warsz) 2015 Feb 7;63(1):79-84. Epub 2014 Nov 7.

Chair and Department of Medical Microbiology, Medical University of Warsaw, Chałubińskiego 5, 02-004, Warsaw, Poland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-014-0320-zDOI Listing
February 2015

Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

Biol Blood Marrow Transplant 2012 Feb 13;18(2):314-7. Epub 2011 Oct 13.

Centre Hospitalier et Universitaire de Nantes, Service d'Hématologie Clinique, Nantes, Université de Nantes, Centre d'Investigation Clinique en Cancérologie (CI2C), INSERM CRNCA UMR 892, Nantes, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791110040
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.10.003DOI Listing
February 2012

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.

Leuk Lymphoma 2011 Sep 12;52(9):1711-9. Epub 2011 Jun 12.

Department of Hematology, Oncology and Internal Diseases, The Medical University of Warsaw, Warsaw, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.578312DOI Listing
September 2011

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.

Am J Hematol 2011 Jul 14;86(7):550-3. Epub 2011 Jun 14.

Department of Hematology, Oncology and Internal Diseases, The Medical University of Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22038DOI Listing
July 2011

Optimization of activation requirements of immature mouse dendritic JAWSII cells for in vivo application.

Oncol Rep 2011 Mar 28;25(3):831-40. Epub 2010 Dec 28.

Department of Immunology, Centre of Biostructure, Medical University of Warsaw, Banacha 1a Street, F Building, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/or/25/3/831
Publisher Site
http://dx.doi.org/10.3892/or.2010.1128DOI Listing
March 2011

Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity.

Blood 2010 May 3;115(18):3745-55. Epub 2010 Mar 3.

Department of Immunology, Center of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-09-244129DOI Listing
May 2010

Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model.

Oncol Rep 2008 May;19(5):1173-9

Department of Immunology, Centre of Biostructure Research, Medical University of Warsaw, 02-097 Warsaw, Poland.

View Article

Download full-text PDF

Source
May 2008